Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density

Area of Science:

• Epigenetics and Molecular Biology
• Genomics and DNA Methylation Analysis

Background:

• DNA methylation is crucial for gene regulation and cellular processes.
• Accurate quantification of regional DNA methylation is essential for understanding epigenetic changes.
• Existing methods for methylation analysis have limitations in precision and scope.

Purpose of the Study:

• To develop a novel, quantitative method for assessing CpG methylation density in specific DNA regions.
• To establish a sensitive and accurate assay for regional methylation analysis in mammalian cells.
• To demonstrate the utility of the new method in studying gene promoter methylation.

Main Methods:

• Genomic DNA undergoes bisulfite modification.
• Target DNA regions are PCR amplified using primers with dam sites.
• Enzymatic quantification using 14C-labeled and 3H-labeled S-adenosyl-L-methionine (SAM) with dam and SssI methyltransferases.
• Enzymatic Regional Methylation Assay (ERMA) uses a 3H/14C signal ratio, standardized with known DNA methylation standards, to determine methylation density.

Main Results:

• ERMA provides rapid and quantitative assessment of CpG methylation density.
• The assay utilizes internal controls for accurate DNA quantity standardization.
• Demonstrated application in measuring methylation density of the p15INK4B tumor suppressor gene promoter.
• Observed changes in methylation density following treatment with demethylating agents.

Conclusions:

• ERMA offers an exact measurement of methylation density for specific DNA regions.
• The technique provides advantages over existing methylation analysis methods.
• ERMA is a valuable tool for epigenetic research, particularly in cancer studies involving gene promoter methylation.